Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis
Perifosine Increases PFS In Phase II Study
Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time
Carfilzomib Demonstrates Clinical Benefit Rate of 64%
Single-Letter Mutation Found Responsible For Waldenstrom’s
New Methods Uncover 1,800 RNAs Linked To Breast Cancer
Gene Expression Analyses Can Guide MDS Treatments
Analysis Reveals Patient Subset With Lower PFS in Phase III Trial
Interim Results Show Vaccine Lowers Breast Cancer Recurrence
CTCs Do Not Affect Survival, But Could Signal Metastases
Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects
Trials Approved by NCI CTEP For the Month of December
FDA Grants Orphan Designation To Photofrin for Mesothelioma
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
- Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted
- In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
